0

XTPL published its financial results for 2023 during a video conference on 26 April. The company generated total revenues of PLN 15.5 million in 2023, including PLN 13.4 million in revenues from the sale of products and services. This is the highest result in the history of the company’s development and an increase of 21% […]

OncoSNAAT is a key project for Genomtec from the perspective of increasing the company’s value and a potential M&A transaction. For this project, the Company has secured funding in excess of PLN 10 million, which was successfully raised from the Company’s shareholders and a foreign investor. These funds guarantee the acceleration of the work. The […]

Wrocław-based biopharmaceutical company Biotts has filed a patent application for transdermal semaglutide and other GLP-1 molecules in the US and plans to launch the finished product by the end of 2026. According to Reuters, the market for semaglutide and similar drugs using GLP-1 analogues will reach $100 billion in annual sales this decade. The company […]

Terrabio, developer of the Terralyzer® mobile rtPCR genetic analyser, has officially completed its EMC assessment.This means that the unique and compact rtPCR platform Terralyzer® does not interfere with the operation of other devices and is immune to emissions from other devices. This is another milestone in the commercialisation of this solution. Follow the company’s progress […]

Biotts S.A. and Bioton S.A. have signed a Proof of Concept agreement to test the feasibility of transporting insulin through the skin using the patented MTC-Y carrier. Bioton will supply insulin for patches, which will enable long-lasting drug delivery through the skin using a transdermal system from Biotts. After the PoC phase, the biotech will […]

The Wroclaw-based biotechnology company has become the first in the world to transport the peptides liraglutide and semaglutide through the skin. The last is a substance used in drugs such as the record-breaking Ozempic and Wegovy from the Danish company NovoNordisk. Transdermally delivered substances belong to the group of glucagon-like peptide-1 (GLP-1) analogs used to […]

Nestmedic S.A., developer of fetal well-being monitoring technology consisting of the Pregnabit Pro device and the Pregnabit Cloud platform, has signed a distribution agreement with Synektik. The Synektik Group provides IT solutions, cutting-edge technology and a full range of services and support to medical institutions in the fields of radiology, oncology, cardiology and neurology. The […]

XTPL placed all 275,000 Series V shares at an issue price of PLN 133. Investor interest was huge and exceeded the value of the offer by several times. The shares will represent 11.9% of the company’s shares. The funds raised from the share issue will be used to commercialise XTPL’s technology in the three business […]

Terrabio, a biotechnology company based in Wrocław, has developed the first mobile genetic analyser available in Poland. This device enables food manufacturers to rapidly detect viruses, bacteria, fungi, or protozoa. The R&D phase is nearing completion, and the company is currently testing the device with potential customers. This marks a significant milestone in Terrabio’s development, […]

On 16th February 2023, Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange. The company had been listed on the New Connect market since March 2021. At the opening, the company’s stock price rose 2.16% to PLN 14.2. Genomtec has clear plans for growth: it has initiated an M&A process with Clairfield Partners […]